Myalgic Encephalomyelitis - A Disease Looking for Respect

RDR Staff
Published Online: Tuesday, Mar 05, 2013

Myalgic encephalomyelitis (ME) is a condition with unknown origin and unclear treatment options. Widespread inflammation and multisystemic neuropathology seem to be at the core of its pathophysiology.

ME is also commonly referred to as chronic fatigue syndrome but advocates for the condition prefer the ME nomenclature. Chronic fatigue syndrome has been often misused and/or over-diagnosed in the past so it is currently unclear if ME is a rare condition. A recent prevalence study (Vincent et al 2012)  had the estimated number of patients in the U.S. at around the 200,000 mark but more studies are needed to ascertain its true prevalence.

In this interview with Rare Disease Report, patient - and patient advocate - Charlotte von Salis describes ME and the need for more awareness and funding for this condition.

For more information about this ME, visit www.name-us.org

Reference

Vincent A, Brimmer DJ, Whipple MO, et al. Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted Country, Minnesota, as estimated using the Rochester epidemiology project. Mayo Clinic Proc.2012; 87(12):1145-52

Related Articles
If your website isn’t mobile friendly, you will drop in Google search results.
Like other rare disorders, special challenges arise in creating new drugs to treat neuromuscular disease, and the rate of new drug approvals to treat these conditions has been slow.
Social entrepreneurship is an important part of orphan drug development and one organization that is embracing that economic model is EspeRare—a non-profit organization designed to develop treatments for rare conditions.
The Muscular Dystrophy Association (MDA) announced they will discontinue production of a broadcast telethon beginning this year to reflect the changing way that people engage in fundraising activities.
External Resources

MJH Associates
AJMC
Cure
MD Magazine
OncLive
Pharmacy Times
Specialty Pharmacy Times
Physicians' Education Resource
Internal Resources

Medicine
Advocacy
Business/Regulratory
Events
Conferences
Connect With Us:

About Us
Advertise
Careers
Contact Us
Privacy Policy
Sponsor
Terms and Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Rare Disease Report 2015
Intellisphere, LLC. All Rights Reserved.